NetworkNewsBreaks – EVIO, Inc. (EVIO) Acquires S
Post# of 2022
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that it has completed the acquisition of 60 percent of C3 Labs, LLC, one of the nation’s first cannabis-focused contract research organizations. EVIO also maintains the option to purchase the remaining ownership stake in C3 Labs for an initial period of three years, subject to C3 member approval. “The addition of C3 Labs to the EVIO network is a tremendous milestone for EVIO Inc.,” William Waldrop, CEO of EVIO, stated in the news release. “C3 Labs generated over $1M in consulting revenues during the last two years, EVIO plans to continue offering these services along with traditional compliance testing. The 8,000 square foot facility is already outfitted with the latest analytical testing equipment, and will become our Northern California hub laboratory… Demand for testing services is expected to increase significantly as the state rolls out its adult-use marijuana market.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer